Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Echa List'
Echa List published presentations and documents on DocSlides.
Managing the risk of industrial chemicals and biocides
by ellena-manuel
Jack de Bruijn. European Chemicals Agency. TOWARD...
Registration deadline has passed, what now?
by kittie-lecroy
Jan HOLOMEK, ReachSpektrum. Chemicals Management ...
Guidance in a Nutshell Identification and naming of substances under REACH and CLP For most uptodate information on Chemicals Safety Assessment please consult the ECHA website
by calandra-battersby
LEGAL NOTICE This document contains guidance on R...
Checking
by debby-jeon
the. Exposure Scenario . Purpose of this presenta...
LES ECHA ࠆduEam T
by phoebe-click
eN SoaHA H
ECHA’s
by mitsue-stanley
focus on improving the information in the supply ...
REACH & CLP
by yoshiko-marsland
Downstream user overview. 1. Purpose of this pres...
REACH and CLP
by lois-ondreau
What formulators need to know. Purpose of this pr...
Welcome
by sherrill-nordquist
ESMA . HSEP Meeting. 07 November . 2014. Apologie...
ANNANKATU 18, P.O. BOX 400, FI00121 HELSINKI, FINLAND |ECHA.EUROPA.EU
by celsa-spraggs
ECHA13GF06ENnformation for partiesinvolvedin REAC...
REACH & CLP
by giovanna-bartolotta
Downstream user overview. 1. Purpose of this pres...
Context
by trish-goza
Brief reminder of REACH – overview and timeline...
REACH and CLP
by olivia-moreira
What formulators need to know. Purpose of this pr...
Lessons
by pamella-moone
. learnt. and challenges . ahead. GPS / REACH ....
Industry view on self-classification issues
by conchita-marotz
23 . October. 2013, Vilnius . Seminar. on . che...
Human Health
by layla
1 MISA 1 workshop Endpoint information requiremen...
How to consider the
by joy
XETA in the assessment strategy of the ECHA/EFSA...
REACH & CLP Downstream user overview
by white
1. Purpose of this presentation. 2. This presentat...
Endocrine disruptors New hazard classification(s) under CLP
by bety
Content. Introduction. Timelines. Impact. New endo...
Load More...